Short Bowel Syndrome Market To Cross Valuation Of US$ 3.66 Bn By 2031

TMR

Short Bowel Syndrome Market: Introduction

According to the report, the global short bowel syndrome market was valued at US$ 728.3 Mn in 2020 and is projected to expand at a CAGR of 15.9% from 2021 to 2031. Incentives and R&D grants for manufacturers of orphan drugs, rise in prevalence of SBS, and favorable reimbursement scenario are anticipated to propel the global short bowel syndrome market. Japan is likely to be a highly lucrative market for short bowel syndrome drugs from 2021 to 2031. The market in the country is projected to expand at a high CAGR during the forecast period.

Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13346

Increase in Demand for SBS Drugs Due to High Cost of Parenteral Nutrition to Drive Market

Most of the short bowel syndrome patients are on parenteral nutrition initially until the patients’ intestine has adopted and hemostasis is being maintained. The cost of parenteral nutrition varies from patient to patient, and ranges between US$ 150,000 and US$ 586,000 per year. The high cost of parenteral nutrition increases demand for short bowel syndrome drugs, which have shown the ability to reduce patient’s dependence on parenteral nutrition during the clinical trials. For instance, apraglutide has the potential to enable patients to minimize the burden from parenteral support by increasing intestinal absorption of fluids, calories, and nutrients. Apraglutide has completed phase 2 studies and is currently being evaluated in a pivotal phase 3 clinical trial. Based on preclinical and clinical data to date, apraglutide has the potential to facilitate the treatment of SBS-IF by establishing less frequent dosing and improving outcomes in a clinically meaningful fashion to address the needs of patients across the anatomical spectrum that characterizes the disease.

Request for Covid-19 Impact Analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=13346

Glucagon-like Peptide-2 (GLP-2) to Dominate Global Market

In terms of product, the global short bowel syndrome market has been classified into glucagon-like peptide-2 (GLP-2), growth hormone, glutamine, and others. The glucagon-like peptide-2 segment dominated the global short bowel syndrome market in 2020, and the trend is projected to continue during the forecast period. The segment’s dominance can be attributed to increase in sales of Gattex/Revestive in the U.S. and Europe. Additionally, it is the only approved drug for the treatment of SBS across the globe.

Retail Pharmacies to be Highly Lucrative Distribution Channel

Based on distribution channel, the global short bowel syndrome market has been divided into hospital pharmacies, retail pharmacies, and online sales. The retail pharmacies segment dominated the global short bowel syndrome market, and the trend is anticipated to continue during the forecast period. The segment is expected to dominate the global short bowel syndrome market due to higher sales of drugs through retail pharmacies in developed countries including the U.S., Europe, and Canada.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=13346

Competition Landscape

Key players in the global short bowel syndrome market include Takeda Pharmaceutical Company Limited, Merck KGaA, Zealand Pharma A/S, OxThera, VectivBio AG, 9 Meters Biopharma, Inc., Nutrinia Ltd., Hanmi Pharm.Co., Ltd., and Pharmascience, Inc.

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: [email protected]

Website: https://www.transparencymarketresearch.com/

TMR

Short Bowel Syndrome Market 2022 Major Key Players and Industry Analysis Till 2030

Anisha Rathore 2023-05-03

COVID-19 Impact Analysis on Short Bowel Syndrome Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and trends for the period 2022-2030. Get more information on "Global Short Bowel Syndrome Market Research Report" by requesting FREE Sample Copy at https://www. Additionally, these tools also give an inclusive assessment of each segment in the global market of short bowel syndrome. Browse Global Short Bowel Syndrome Market Research Report with detailed TOC at https://www. Purchase Complete Global Short Bowel Syndrome Market Research Report at https://www.

Short Bowel Syndrome Market Covid19 Impact Analysis And Forecast 2022-2028

Rahul Kumar Yadav 2023-07-28

Before the COVID-19 pandemic, the Short Bowel Syndrome Market was already witnessing steady growth owing to an increasing prevalence of the disease and advancements in medical treatments. The pandemic had both direct and indirect impacts on the Short Bowel Syndrome Market. In the short term, healthcare facilities faced challenges in providing uninterrupted access to treatments and medications for SBS patients. On the other hand, the pandemic also accelerated certain trends that could positively impact the Short Bowel Syndrome Market in the long term. The COVID-19 pandemic had a mixed impact on the Short Bowel Syndrome Market.

The Path of Wellness: Insights and Strategies for Short Bowel Syndrome

shradha bhandare 2023-06-06

Additionally, it is based on how recently you had your small intestine removed. Your remaining intestine gradually adjusts after surgery. Depending on how much and what portion of your small intestine was removed, this varies. Through a feeding tube, this delivers liquid sustenance directly to your stomach or small intestine. The care of the three phases of SBS—the acute period, the adaption phase, and the maintenance phase—is essential to the patient's recovery from Short Bowel Syndrome.

Short Bowel Syndrome Market Connected with High Cost of Immunotherapy Treatment as a Part of Heading

Leena Shedmake 2023-10-25

The global Short Bowel Syndrome Market is estimated to be valued at US$ 188. Porter's Analysis Threat of new entrants: The threat of new entrants is moderate as the short bowel syndrome market requires high R&D investments. Threat of new substitutes: The threat of new substitutes is low as there are limited treatment options available for short bowel syndrome currently. 5% over the forecast period, due to increasing incidence of short bowel syndrome worldwide. Regional analysis: North America dominates the global short bowel syndrome market due to increasing awareness and availability of advanced treatments.

Irritable Bowel Syndrome Treatment Market Dynamic Outlook and Influencing Key Growth

nilesh 2022-02-21

According to Market Research Future (MRFR)’s new study, the global irritable bowel syndrome treatment market is projected to thrive at a CAGR of 7. Furthermore, the collaborations among the key players are supposed to have a positive influence on the proliferation of the irritable bowel syndrome treatment market. com/sample_request/7044 Global Market for Irritable Bowel Syndrome Treatment – Segmental analysis:This MRFR report offers a detailed segmental analysis of the global irritable bowel syndrome treatment market based on type, drug type, and end-user. By drug type, the irritable bowel syndrome treatment market has been segmented into lubiprostone, linaclotide, eluxadoline, rifaximin, alosetron, and others. The irritable bowel syndrome treatment market in Asia Pacific is poised to witness significant growth in the upcoming years.

Irritable Bowel Syndrome Treatment Market 2020: Global Industry Exhibits Huge Growth by Top Key Players

nilesh 2021-11-23

According to Market Research Future (MRFR)’s new study, the global irritable bowel syndrome treatment market is projected to thrive at a CAGR of 7. Furthermore, the collaborations among the key players are supposed to have a positive influence on the proliferation of the irritable bowel syndrome treatment market. com/sample_request/7044 Global Market for Irritable Bowel Syndrome Treatment – Competitive Dashboard:Some of the key players profiled in the report are Abbott, Allergan Inc. By drug type, the irritable bowel syndrome treatment market has been segmented into lubiprostone, linaclotide, eluxadoline, rifaximin, alosetron, and others. The irritable bowel syndrome treatment market in Asia Pacific is poised to witness significant growth in the upcoming years.

WHO TO FOLLOW

MORE FROM AUTHOR

Pericardial Patches Market Is Booming Across The Globe Exlored In Latest Research

TMR 2022-07-04

Trocars Market Study Landscape And Industry Innovations Encountered Huge Growth By 2027

TMR 2022-07-01

Home Diagnostics Market Study Landscape And Industry Innovations Encountered Huge Growth By

TMR 2022-06-30

Physical Therapy Services Market Foreseen To Grow Exponentially Over 2020 - 2030

TMR 2022-06-29

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.

Press enter to search

Irritable Bowel Syndrome Drugs Market Growth to Witness a Surge by Rise in Prevalence of the Disease with a Notable CAGR during 2020 – 2029

Vijeta tikkiwal 2023-02-09

Research Nester published a report titled “Irritable Bowel Syndrome Drugs Market: Global Demand Analysis & Opportunity Outlook 2029” which delivers detailed overview of the irritable bowel drugs market in terms of market segmentation by type, by product, by end user and by region. The irritable bowel syndrome drug market is anticipated to record a significant CAGR over the forecast period, i. com/sample-request-3040The irritable bowel syndrome drug market is segmented into five main regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. com/sample-request-3040 However, growing completion among major market players is expected to operate as key restraint to the growth of irritable bowel syndrome drugs market in the near future. This report also provides the existing competitive scenario of some of the key players of the irritable bowel syndrome drugs market which includes company profiling of Abbott Services (NYSE: ABT), Ardelyx, Inc.

Irritable Bowel Syndrome with Constipation Drugs Market Growth, Trends, Forecast and COVID-19 Impacts (2020 – 2029)

researchnester.insights 2021-07-29

Research Nester published a report titled “Irritable Bowel Syndrome Drugs Market: Global Demand Analysis & Opportunity Outlook 2029” which delivers detailed overview of the irritable bowel drugs market in terms of market segmentation by type, by product, by end user and by region.Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.The irritable bowel syndrome drug market is anticipated to record a significant CAGR over the forecast period, i.e., 2021 – 2029, owing to the rising geriatric population, increase in the occurrence of gastrointestinal disorders, growing stress levels of people globally, and unhealthy eating habits.

Additionally, escalating advertising campaigns for the treatment of gastrointestinal disorders and increasing usage of over the counter drugs that relieve the symptoms of IBS are other reasons contributing to market growth in the coming years.The market is segmented by type into IBS with diarrhea (IBS-D), IBS with constipation (IBS-C) and mixed IBS (IBS-M), out of which IBS with diarrhea (IBS-D) segment is predicted to hold leading share in the irritable bowel syndrome drugs market on account of rising cases of gastrointestinal disorders such as constipation and diarrhea owing to sedentary lifestyle and increased intake of medications such as linaclotide and lubiprostone worldwide.Download Sample of This Strategic Report: https://www.researchnester.com/sample-request-3040The irritable bowel syndrome drug market is segmented into five main regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

The North American region holds the largest market share owing to the availability of cheap fast food and sedentary lifestyle changes of the population.

On the other hand, Asia-Pacific is expected to witness the highest growth during the forecast period on the back of rise in the number of hospitals equipped with specialist surgical services, and growing advancements in healthcare technology.Growth in the Prevalence of Irritable Bowel Syndrome to Boost Market GrowthAs a result of increasing trend of sedentary lifestyle patterns, there has been a hike in the number of cases reporting gastrointestinal disorders which further trigger irritable bowel syndrome.

This has led to the production of new drugs, which are symptom specific, by key market players, which in turn is anticipated to fuel the growth of the market over the forecast period.“The Final Report will cover the impact analysis of COVID-19 on this industry.”Download/Request Sample Copy of Strategic Report: https://www.researchnester.com/sample-request-3040However, growing completion among major market players is expected to operate as key restraint to the growth of irritable bowel syndrome drugs market in the near future.This report also provides the existing competitive scenario of some of the key players of the irritable bowel syndrome drugs market which includes company profiling of Abbott Services (NYSE: ABT), Ardelyx, Inc. (NASDAQ: ARDX), Astellas Pharma Inc (TYO: 4503), AstraZeneca (LON: AZN), GlaxoSmithKline Plc (LON: GSK), Johnson & Johnson Services, Inc. (NYSE: JNJ), Novartis AG (SWX: NOVN), Ironwood Pharmaceuticals, Inc (NASDAQ: IRWD), Synergy Pharma Consultancy Private Limited, Synthetic Biologics, Inc (NYSEAMERICAN: SYN), and others.

On the whole, the report depicts detailed overview of the global irritable bowel syndrome drugs market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

What Can Trigger Irritable Bowel Syndrome?

Avalon Hospital 2023-10-31

Irritable bowel syndrome, commonly known as IBS, is a group of symptoms associated with the digestive system. This gastrointestinal disorder leads to excessive buildup of gas, abdominal cramps, abdominal bloating, abdominal pain, etc. If you suspect you have IBS or symptoms like ongoing abdominal pain, changes in bowel movements, too much gas, constipation or diarrhea, or both, mucus in your poop, consult a healthcare provider. It’s the activation of IBS symptoms due to food intolerance, certain medication intake, stress, or lifestyle factors. Fluctuations in estrogen and progesterone impact your period, gut, and IBD symptoms like abdominal pain, diarrhea, bloating, and vomiting.

Irritable Bowel Syndrome Treatment consists of a variety of medications and other therapies that assist patients suffering from this condition.

CMI Blogging 2021-10-06

Traditional irritable bowel syndrome therapy typically consists of using medications to suppress the symptoms in those who have been diagnosed with the condition.

The medicine used to treat irritable bowel syndrome is termed as "suppression" or "antibiotic."

The inhibition of the immune system is another untested advantage of this method.Recent research suggests that immunomodulators, a relatively new kind of irritable bowel syndrome therapy, can have a positive effect.

This new family of medicines, which is currently under research, works by influencing the cells that create immune responses to maintain a healthy gut lining.

These cells appear to create a protective response that inhibits the occurrence of diarrhea.

The aim is that this will be a successful long-term treatment for irritable bowel syndrome, and that it may even improve the efficacy of traditional therapies to ease symptoms.

"Patient-Centric Approaches in the IBS Treatment Market"

Sumedha 2023-10-12

The IBS treatment market has seen significant developments in recent years, offering hope to those affected. Various approaches are now available to manage IBS symptoms, ranging from dietary modifications and lifestyle changes to medication and alternative therapies. One of the most noteworthy trends in IBS treatment is the growing emphasis on personalized care. Healthcare providers are increasingly tailoring treatment plans to individual patients' needs, recognizing that IBS can manifest differently in each person. The IBS treatment market is continually evolving, offering a diverse range of options to cater to the unique needs of IBS sufferers.

Irritable Bowel Syndrome (IBS) Treatment Market Industry Size, Trends, Key Players Analysis and Forecast 2032

Soffi Clark 2023-02-27

"According to the research report, the global irritable bowel syndrome (IBS) treatment market was valued at USD 3. "Polaris Market Research has introduced the latest market research report titled Irritable Bowel Syndrome (Ibs) Market: By Size, Trends, Share, Growth, Segments, Industry Analysis and Forecast, 2032 that highlights the major revenue stream for the forecast period. The report focuses on Irritable Bowel Syndrome (Ibs) Market size, share, growth status, future trends, volume, and key market dynamics. The report provides a comprehensive analysis of the market with respect to dynamics, competitive analysis, and upcoming Irritable Bowel Syndrome (Ibs) Market trends. About Us:Polaris Market Research is a worldwide market research and consulting organization.

Suits Prunie Recipe

Umanitya Ramesh 2019-07-11

Louis Litt swears by a prunie and just can’t do without it.

We felt after trying it that even if you don’t have Grandma Gertie’s spastic colon you’ll still find it refreshing.

So go ahead and try out this detoxifying prunie recipe!

Nurturing Gut Health: Exploring the Best Probiotics and Their Benefits for IBS and Diverticulitis

Custom Probiotics Inc. 2023-12-29

In the realm of digestive health, probiotics have garnered significant attention for their potential to promote a balanced and thriving gut microbiome. Understanding Probiotics: Probiotics are live microorganisms, primarily beneficial bacteria, that confer health benefits when consumed in adequate amounts. Key Characteristics of the Best Probiotics:Strain Specificity: Different strains of probiotics offer distinct health benefits. Considerations:Strain Compatibility: Match probiotic strains to the targeted health benefits required, such as IBS symptom relief or Diverticulitis support. Conclusion: In the journey to optimal digestive health, the search for the best probiotics becomes a crucial component.

How Hypnosis Can Help to Cure Irritable Bowel Syndrome Or IBS

elynaelina 2023-03-20

Let's know more about what causes IBS and hypnosis techniques for IBS treatment:What Causes IBS? Studies have shown that hypnosis can effectively reduce IBS symptoms such as bloating, abdominal pain, and diarrhea and that the benefits can be long-lasting. In hypnotherapy for IBS, patients may be guided through a series of mental exercises in which they imagine themselves in a peaceful, relaxing environment. DesensitizationDesensitization is a technique in which patients are gradually exposed to the things that trigger their IBS symptoms. Gut-Directed HypnotherapyGut-directed hypnotherapy is a specific type of hypnotherapy tailored to IBS patients' needs.

Irritable Bowel Syndrome Treatment Market 2022 Global Share, Revenue, Profit Margin, Major Product Portfolio and SWOT Analysis, Applications, New Technology, Forecast Period till 2028

Digital kurhade 2022-09-16

It contains a requirement prediction, a close clarification of assumptions and techniques, also as ancient records and projections. This takes a glance at checked-out market innovations that have previously gained momentum and are anticipated to attain this within the destiny. Regional AnalysisThe report's Irritable Bowel Syndrome Treatment zone assessment and interpretation is popping increasingly more reliant on nearby studies. The top-to-backside techniques of massive businesses are tested during this marketplace take a glance at. This portion of the document carries contact information for extensive suppliers within the Irritable Bowel Syndrome Treatment enterprise.

I Have Irritable Bowel Syndrome T Shirt

MH Bijoy 2021-06-21

I Have Irritable Bowel Syndrome T ShirtI Have Irritable Bowel Syndrome T Shirt shirts, apparel, posters are available at TeeChip.https://teechip.com/I-Have-Irritable-Bowel-Syndrome-T-Shirt

Irritable Bowel Syndrome

Adi Intellect 2019-05-30

Irritable bowel syndrome (IBS) is a digestive system disorder in which a person experiences multiple symptoms that impacts his/her daily life.

Irritable bowel syndrome affects 10-15% of the population around the world, but the exact cause of IBS is unknown.

The occurrence of IBS is higher in women than in men.

People with a prior digestive tract infection, stressful lifestyle, and family history of IBS are more likely to develop the disorder [NIH].

Irritable bowel syndrome is of three types – irritable bowel syndrome with diarrhea (IBS-D), irritable bowel syndrome with constipation (IBS-C) and irritable bowel syndrome with alternating constipation and diarrhea (IBS-A).

Irritable Bowel Syndrome (IBS) Market CAGR of 12.45% is Ready to Grow Globally with Phenomenal Trend Diversity Forecast by 2026

ethan ethan 2021-02-19

Irritable Bowel Syndrome Market syndrome is a division of Telehealth market.

Another report by International Foundation of Gastrointestinal Disorders, mental disorders, suggests that worldwide prevalence rates were 10–15% in 2016.

Same report says that there were around 2.4-3.5 million annual physician visits for IBD in the US alone.

The report also recognizes and analyses the rising trends along with major drivers, challenges and opportunities in the market.

This Hepatic Encephalopathy Treatment Market report provides major statistics on the market status of global and regional manufacturers and is a helpful source of assistance and direction for companies and individuals interested in Healthcare industry.

The company profiles of all the chief and dominating market players and brands who are taking steps such as product launches, joint ventures, mergers and acquisitions are mentioned in the report.Access insightful study with over 100+ pages, list of tables & figures, profiling 10+ companies.

How Can Homeopathic Medicine for Irritable Bowel Syndrome Help

Excel Pharma 2022-07-06

Today you can get an online consultation from a qualified Homeopathic doctor and order your Homeopathic Medicine for Irritable Bowel Syndrome Online. The following are the most common signs of this disease:· Abdominal cramping and pain generally that comes and goes,· The patient feels relief after a bowel movement· Gas and bloating· Diarrhea or constipation· Feeling compelled to make a second bowel movement right after finishing the first· Mucus in your stoolCauses of IBSThere is no exact etiology (cause) of Irritable bowel syndrome. The following health issues are known to trigger and worsen IBS:· A malfunction in the gut-brain axis (the way through which the brain sends signs to the gut)· Having trouble digesting food properly· A bacterial infection in the gastrointestinal system· Food Allergy· Genetics play a major role· Depression and anxiety are other factors causing IBS. Other than medications, Homeopathic doctors can advise the following-· Consult a dietitian for suggestions on meals that are easy to digest. Before taking any Homeopathic Medicine for Irritable Bowel Syndrome, IBS patients should always speak with a qualified Homeopath.

Irritable Bowel Syndrome Drugs Market Growth to Witness a Surge by Rise in Prevalence of the Disease with a Notable CAGR during 2020 – 2029

Vijeta tikkiwal 2023-02-09

How Hypnosis Can Help to Cure Irritable Bowel Syndrome Or IBS

elynaelina 2023-03-20

Irritable Bowel Syndrome with Constipation Drugs Market Growth, Trends, Forecast and COVID-19 Impacts (2020 – 2029)

researchnester.insights 2021-07-29

Research Nester published a report titled “Irritable Bowel Syndrome Drugs Market: Global Demand Analysis & Opportunity Outlook 2029” which delivers detailed overview of the irritable bowel drugs market in terms of market segmentation by type, by product, by end user and by region.Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.The irritable bowel syndrome drug market is anticipated to record a significant CAGR over the forecast period, i.e., 2021 – 2029, owing to the rising geriatric population, increase in the occurrence of gastrointestinal disorders, growing stress levels of people globally, and unhealthy eating habits.

The North American region holds the largest market share owing to the availability of cheap fast food and sedentary lifestyle changes of the population.

Irritable Bowel Syndrome Treatment Market 2022 Global Share, Revenue, Profit Margin, Major Product Portfolio and SWOT Analysis, Applications, New Technology, Forecast Period till 2028

Digital kurhade 2022-09-16

What Can Trigger Irritable Bowel Syndrome?

Avalon Hospital 2023-10-31

I Have Irritable Bowel Syndrome T Shirt

MH Bijoy 2021-06-21

I Have Irritable Bowel Syndrome T ShirtI Have Irritable Bowel Syndrome T Shirt shirts, apparel, posters are available at TeeChip.https://teechip.com/I-Have-Irritable-Bowel-Syndrome-T-Shirt

Irritable Bowel Syndrome Treatment consists of a variety of medications and other therapies that assist patients suffering from this condition.

CMI Blogging 2021-10-06

Traditional irritable bowel syndrome therapy typically consists of using medications to suppress the symptoms in those who have been diagnosed with the condition.

The medicine used to treat irritable bowel syndrome is termed as "suppression" or "antibiotic."

This new family of medicines, which is currently under research, works by influencing the cells that create immune responses to maintain a healthy gut lining.

These cells appear to create a protective response that inhibits the occurrence of diarrhea.

The aim is that this will be a successful long-term treatment for irritable bowel syndrome, and that it may even improve the efficacy of traditional therapies to ease symptoms.

"Patient-Centric Approaches in the IBS Treatment Market"

Sumedha 2023-10-12

Irritable Bowel Syndrome

Adi Intellect 2019-05-30

Irritable bowel syndrome (IBS) is a digestive system disorder in which a person experiences multiple symptoms that impacts his/her daily life.

Irritable bowel syndrome affects 10-15% of the population around the world, but the exact cause of IBS is unknown.

The occurrence of IBS is higher in women than in men.

People with a prior digestive tract infection, stressful lifestyle, and family history of IBS are more likely to develop the disorder [NIH].

Irritable Bowel Syndrome (IBS) Treatment Market Industry Size, Trends, Key Players Analysis and Forecast 2032

Soffi Clark 2023-02-27

Irritable Bowel Syndrome (IBS) Market CAGR of 12.45% is Ready to Grow Globally with Phenomenal Trend Diversity Forecast by 2026

ethan ethan 2021-02-19

Irritable Bowel Syndrome Market syndrome is a division of Telehealth market.

Another report by International Foundation of Gastrointestinal Disorders, mental disorders, suggests that worldwide prevalence rates were 10–15% in 2016.

Same report says that there were around 2.4-3.5 million annual physician visits for IBD in the US alone.

The report also recognizes and analyses the rising trends along with major drivers, challenges and opportunities in the market.

Suits Prunie Recipe

Umanitya Ramesh 2019-07-11

Louis Litt swears by a prunie and just can’t do without it.

We felt after trying it that even if you don’t have Grandma Gertie’s spastic colon you’ll still find it refreshing.

So go ahead and try out this detoxifying prunie recipe!

How Can Homeopathic Medicine for Irritable Bowel Syndrome Help

Excel Pharma 2022-07-06

Nurturing Gut Health: Exploring the Best Probiotics and Their Benefits for IBS and Diverticulitis

Custom Probiotics Inc. 2023-12-29